NHLD News and Press, National Holdings Corporation From 12/05/19

NEW YORK , Dec. 5, 2019 /PRNewswire/ -- Healthcare Trust, Inc. ("HTI" or the "Company") today announced the pricing of an underwritten public offering of 1,400,000 shares of its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock (the "Series A Preferred Stock") at a publ...

NEW YORK , Dec. 5, 2019 /PRNewswire/ --  WhiteHorse Finance, Inc. , a business development company (the "Company") (Nasdaq: WHF), today announced that certain of its stockholders (the "Selling Stockholders"), which are funds affiliated with H.I.G. Capital, LLC ("H.I.G. Capital"), hav...

NEW YORK , Dec. 5, 2019 /PRNewswire/ -- Healthcare Trust, Inc. ("HTI" or the "Company") today announced the launch of a proposed underwritten public offering of 1,400,000 shares of its Series A Cumulative Redeemable Perpetual Preferred Stock (the "Series A Preferred St...

NEW YORK , Dec. 4, 2019 /PRNewswire/ -- WhiteHorse Finance, Inc., a business development company (the "Company") (Nasdaq:WHF), today announced that certain of its stockholders (the "Selling Stockholders"), which are funds affiliated with H.I.G. Capital, LLC ("H.I.G. Capital"), pla...

NEW YORK , Nov. 20, 2019 /PRNewswire/ -- Global Net Lease, Inc. (NYSE: GNL) ("GNL" or the "Company") today announced the pricing of an underwritten public offering of 3,000,000 shares of its 6.875% Series B Cumulative Redeemable Perpetual Preferred Stock (the "Series B Preferred Stoc...

NEW YORK, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced the pricing of its previously announced underwritten public offering. Checkpoint is offering 1...

NEW YORK, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that it is proposing to offer and sell, subject to market conditions, shares of its common sto...

EVANSTON, Ill., Oct. 23, 2019 (GLOBE NEWSWIRE) -- Fidus Investment Corporation (NASDAQ:FDUS) (“Fidus” or the “Company”) today announced that, in connection with its previously disclosed registered public offering of $55.0 million aggregate principal amount o...

EVANSTON, Ill., Oct. 16, 2019 (GLOBE NEWSWIRE) -- Fidus Investment Corporation (NASDAQ:FDUS) (“Fidus” or the “Company”) today announced that it has closed a registered public offering of $55.0 million aggregate principal amount of its 5.375% notes due 2024 (...

Fortress Biotech ( FBIO ) has made significant progress since my 11/24/2018 article on the Fortress Biotech Inc. 9.375% Cum Conv Perp Red Pfd Registered Shs Series ( FBIOP ). Although FBIOP remains a speculative issue, it has appreciated in price from $17.58 to $20.00 since my last artic...